We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics

By MedImaging International staff writers
Posted on 03 Feb 2026
Image: Nuclear medicine adoption is drive by increasing demand for accurate disease characterization in oncology, cardiology, and neurology (Adobe Stock)
Image: Nuclear medicine adoption is drive by increasing demand for accurate disease characterization in oncology, cardiology, and neurology (Adobe Stock)

Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion of nuclear medicine, indicating how modalities, end users, and regions are likely to drive growth through 2030.

The analysis by MarketsandMarkets forecasts the nuclear medicine market to grow from USD 10.41 billion in 2025 to USD 21.01 billion by 2030, representing a 15.1% compound annual growth rate. Diagnostic nuclear medicine held a larger share than therapeutic applications in 2024, reflecting widespread use of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for noninvasive detection and longitudinal monitoring. Continued radiotracer innovation and imaging system advancements are cited as contributors to diagnostic utility.

Adoption is being propelled by the need for accurate disease characterization in oncology, cardiology, and neurology. Expanding theranostic approaches and the introduction of novel radioisotopes are moving the field toward more personalized, targeted care. Improvements such as digital PET, AI-based image analysis, and automated dose dispensing are described as enhancing diagnostic precision and operational efficiency.

Hospitals are projected to be the fastest-growing end user segment. Investment in advanced imaging suites, development of in-house nuclear medicine capabilities, and expansion of hospital radiopharmacies are highlighted as drivers. Integrated diagnostic services that streamline workflow and support multidisciplinary decision-making are expected to reinforce this trajectory.

North America is projected to lead regional growth. The region’s established radiopharmaceutical manufacturing and distribution networks, strong healthcare infrastructure, wide access to nuclear medicine services, and an active regulatory environment supporting new tracers and indications are identified as key factors. 

Related Links
MarketsandMarkets

X-Ray Illuminator
X-Ray Viewbox Illuminators
Medical Radiographic X-Ray Machine
TR30N HF
Mobile X-Ray System
K4W
Half Apron
Demi

Channels

Ultrasound

view channel
Image: The super-resolution lymphatic imaging system could diagnose and monitor patients with lymphatic disease (Photo courtesy of Adobe Stock)

Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time

Lymphatic disorders affect hundreds of millions of people worldwide and are linked to conditions ranging from limb swelling and organ dysfunction to birth defects and cancer-related complications.... Read more

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.